Walleye Capital LLC Eagle Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$25.06 - $34.09 $140,912 - $191,688	5,623 Added 51.91%	16,455 $466,000
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $270,583 - $430,788	10,832 New	10,832 $316,000
Q2 2022 Aug 08, 2022	SELL	$41.26 - $51.35 $353,845 - $440,377	-8,576 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $382,318 - $451,097	8,576 New	8,576 $424,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $7,698 - $13,455	-224 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $39,979 - $47,332	-736 Reduced 76.67%	224 $13,000
Q3 2019 Nov 14, 2019	BUY	$53.25 - $59.98 $27,477 - $30,949	516 Added 116.22%	960 $54,000
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $16,033 - $20,106	344 Added 344.0%	444 $25,000
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $3,865 - $5,182	100 New	100 $5,000

8.56M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $9.11M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.